Shu Ping Gao
Président chez Hebei Hanlin Biotechnology Co., Ltd.
Profil
Shu Ping Gao is currently the Chairman at Hebei Hanlin Biotechnology Co., Ltd.
and a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
In the past, Gao worked as a Director at SSY Group Ltd.
from 2009 to 2012 and as a Director & Vice General Manager at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Gao completed an undergraduate degree at Hebei University of Science & Technology.
Postes actifs de Shu Ping Gao
| Sociétés | Poste | Début |
|---|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Directeur/Membre du Conseil | 25/03/2010 |
Hebei Hanlin Biotechnology Co., Ltd.
 Hebei Hanlin Biotechnology Co., Ltd. BiotechnologyHealth Technology Hebei Hanlin Biotechnology Co. Ltd. engages in the manufacture of biotechnological products. It offers custom peptide synthesis, secondary, monoclonal and polyclonal antibodies, cell culture medium, and custom antibody-related services. The company was founded on February 25, 2011 and is headquartered in Shijiazhuang, China. | Président | - |
Anciens postes connus de Shu Ping Gao
| Sociétés | Poste | Fin |
|---|---|---|
| SSY GROUP LIMITED | Directeur/Membre du Conseil | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Directeur/Membre du Conseil | - |
Formation de Shu Ping Gao
| Hebei University of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
Hebei Hanlin Biotechnology Co., Ltd.
Hebei Hanlin Biotechnology Co., Ltd. BiotechnologyHealth Technology Hebei Hanlin Biotechnology Co. Ltd. engages in the manufacture of biotechnological products. It offers custom peptide synthesis, secondary, monoclonal and polyclonal antibodies, cell culture medium, and custom antibody-related services. The company was founded on February 25, 2011 and is headquartered in Shijiazhuang, China. | Health Technology |
